The enormity of pollution due to pharmaceuticals in India has caught the attention of researchers all over the world. This was due to the near extinction of vultures in the Indian subcontinent in the 1990s caused by diclofenac and a recent study in 2007 by Swedish scientists on pharmaceutical effl uents in Patancheru in Hyderabad. The massive outsourcing of pharmaceutical production by the west has made third world nations like India a victim of unbridled opportunism. As the west wakes up to the environmental implications of "pharma pollution", Sweden's Medical Products Agency recommends a reduction in outsourcing and revisions in pharma manufacturing practices. Would these exhortations reduce pharmaceutical pollution in India or would they adversely impact India's advantages in the global drug market?
